References
- Lundstrom E, Wilczek B, von Palffy Z, Soderqvist G, von Schoultz B. Mammographic breast density during hormone replacement therapy: effects of continuous combination, unopposed transdermal and low-potency estrogen regimens. Climacteric 2001;4:42–8
- Laya MB, Gallagher JC, Schreiman JS, Larson EB, Watson P, Weinstein L. Effect of postmenopausal hormonal replacement therapy on mammographic density and parenchymal pattern. Radiology 1995;196:433–7
- Rutter CM, Mandelson MT, Laya MB, Taplin S. Changes in breast density associated with initia-tion, discontinuation, and continuing use of hormone replacement therapy. J Am Med Assoc 2001;285:171–6
- Greendale GA, Reboussin BA, Sie, A, et al. Effects of estrogen and estrogen—progestin on mammo-graphic parenchymal density. Ann Intern Med 1999;130:262–9
- Schairer C, Lubin J, Troisi R, Sturgeon S, Brinton I, Hoover R. Menopausal estrogen and estrogen—progestin replacement therapy and breast cancer risk. J Am Med Assoc 2000;283:485–91